TAYLOR KOHLS: Open Payments
NPI 1851060024 · CENTERVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,515 in 212 payments from 34 companies in 2025. Trend: 2023 $3,937 · 2024 $3,841 · 2025 $4,515
Food & beverage: $4,497Speaker / faculty: $18
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $608 |
| EMD Serono, Inc. | 7 | $372 |
| Lilly USA, LLC | 11 | $292 |
| Amneal Pharmaceuticals LLC | 12 | $247 |
| Eisai Inc. | 11 | $227 |
| Novartis Pharmaceuticals Corporation | 14 | $225 |
| PFIZER INC. | 15 | $219 |
| Neurocrine BioSciences, Inc. | 12 | $217 |
| Biogen, Inc. | 12 | $203 |
| UCB, Inc. | 10 | $191 |
Products named: QULIPTA, CREXONT, Leqembi, KESIMPTA, INGREZZA, NUPLAZID, VYALEV, VYEPTI.
Industry payments across OH — which companies pay providers there.
